Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 18, No 6 (2022) Predictors of Long-Term Outcomes after Surgical Myocardial Revascularization Abstract  similar documents
V. S. Kaveshnikov, M. A. Kuzmichkina, V. N. Serebryakova
"... High mortality from cardiovascular diseases (CVD) requires improved approaches to the treatment ..."
 
Vol 14, No 5 (2018) Impact of Pre-Diabetes on the Rate of Major Adverse Cardiovascular Events in Patients Undergoing Coronary Artery Bypass Grafting Abstract  similar documents
A. N. Sumin, N. A. Bezdenezhnykh, A. V. Bezdenezhnykh, S. V. Ivanov, O. L. Barbarash
"...   artery bypass grafting (CABG). Material and methods. 347 CAD patients who underwent CABG in the period ..."
 
Vol 18, No 5 (2022) Clinical and Anamnestic Characteristics, Cardiovascular Pharmacotherapy and Long-term Outcomes in Multimorbid Patients after COVID-19 Abstract  similar documents
A. A. Smirnov, M. M. Loukianov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Maltseva, E. N. Belova, V. G. Klyashtorniy, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina
"... Aim. To study the clinical and anamnestic characteristics, pharmacotherapy of cardiovascular ..."
 
Vol 14, No 5 (2018) Effect of Previous Cardiovascular Diseases on Long-Term Outcomes of Acute Myocardial Infarction: Data of the Outpatient Registry "PROFILE-IM” Abstract  similar documents
N. P. Kutishenko, D. P. Sichinava, E. P. Kalaydzhyan, V. A. Evdakov, E. A. Kasparova, S. Yu. Martsevich
"... (AMI), to assess the influence of factors in medical history, especially cardiovascular diseases (CVD ..."
 
Vol 11, No 6 (2015) The influence of concomitant diseases on a long-term prognosis in patients with chronic ischemic heart disease according to the PROGNOZ IBS register Abstract  similar documents
S. N. Tolpygina, S. Yu. Martsevich, A. D. Deev
"... in the survival analysis. Risk factors of cardiovascular diseases, associated with atherosclerosis, or those ..."
 
Vol 4, No 4 (2008) PRIORITIES IN CONCEPT OF CARDIOVASCULAR RISK FACTORS IN IRRADIATED PATIENTS AT DISTANT PERIOD AFTER CHERNOBYL NUCLEAR DISASTER BASED ON PROSPECTIVE COHORT DATA Abstract  similar documents
R. G. Oganov, V. S. Sherashov, N. V. Sherashova, M. V. Sherashova, S. K. Kukushkin, O. G. Rudakova, E. A. Zhavoronkova
"... Aim. To study pathogenetic mechanisms and cardiovascular risk factors prospective cohort study ..."
 
Vol 18, No 2 (2022) Sequelae of COVID-19 at long-term follow-up after hospitalization Abstract  PDF (Eng)  similar documents
N. V. Pogosova, F. N. Paleev, A. K. Ausheva, D. T. Kuchiev, S. A. Gaman, T. N. Veselova, M. B. Belkind, O. Yu. Sokolova, R. A. Zhetisheva, S. K. Ternovoy, S. A. Boytsov
"... information on their vital status, cardiovascular and other conditions or their complications, and new ..."
 
Vol 20, No 6 (2024) Medical treatment of cardiovascular diseases in patients after hospitalization for COVID-19 (three-year follow-up data in the TARGET-VIP registry) Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, M. M. Loukianov, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, E. Yu. Okshina, A. A. Smirnov, A. G. Soplenkova, A. A. Pulin, N. N. Kuzina, D. A. Nefedova, V. G. Klyashtorniy, O. E. Karpov, O. M. Drapkina
"... Aim. To evaluate the quality of drug treatment of patients with cardiovascular diseases (CVD ..."
 
Vol 4, No 3 (2008) OMEGA-3 POLYUNSATURATED FATTY ACIDS IN ATRIAL FIBRILLATION PREVENTION AFTER SURGICAL MYOCARDIAL REVASCULARIZATION Abstract  similar documents
A. V. Panov, B. A. Tatarskiy, M. L. Gordeev, R. I. Nilk
"... with ischemic heart disease (IHD) before and after coronary artery bypass graft (CABG). Material and methods ..."
 
Vol 14, No 2 (2018) REGISTRY OF ACUTE CEREBRAL CIRCULATORY DISORDERS LIS-2: NEW DATA ON LONG-TERM FOLLOW-UP Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, A. V. Zagrebelnyy, Yu. V. Lukina, М. L. Ginzburg, A. V. Fokina, E. V. Daniels, A. D. Deev
"... , other cardiovascular diseases – in 18%, oncological diseases – in 7%, injuries – in 4%. Such causes ..."
 
Vol 13, No 1 (2017) THE STUDY "REGISTER OF PATIENTS AFTER ACUTE STROKE (REGION)". PART 2. OUTPATIENT PROSPECTIVE REGISTER OF PATIENTS AFTER ACUTE STROKE (ACCORDING TO THE RESULTS OF THE PILOT PHASE OF THE STUDY) Abstract  PDF (Eng)  similar documents
S. А. Boytsov, M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, L. V. Stakhovskaya, A. N. Vorobyev, A. V. Zagrebelnyy, N. P. Kutishenko, A. N. Kozminsky, K. A. Moseichuk, K. G. Pereverzeva, E. A. Pravkina, E. N. Belova, E. V. Kudryashov, A. D. Deev
"... , concomitant cardiovascular diseases (CVD) and noncardiac diseases were analyzed. We estimated accordance ..."
 
Vol 9, No 5 (2013) THE ROLE OF LIPOTROPIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE BEFORE AND AFTER CORONARY REVASCULARIZATION Abstract  similar documents
R. N. Adzhiev, M. S. Safarova, M. V. Ezhov
"... , Post-CABG, TNT) and meta-analyzes on the role of statins, prescribed before and after coronary artery ..."
 
Vol 16, No 3 (2020) The Main Cardiovascular Complications and Mortality Rates During the First One and a Half Years after Acute Myocardial Infarction: Data from the Prospective Outpatient Registry PROFILE-IM Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, D. P. Sichinava, E. P. Kalaydzhyan, E. A. Kasparova, A. V. Zagrebelnyy, Yu. V. Lukina, V. A. Evdakov
"... was 1.5 years. The primary combined endpoint (PCE) included death from any cause, cardiovascular events ..."
 
Vol 8, No 3 (2012) PHARMACOECONOMIC ASPECTS OF NICOTINE ADDICTION TREATMENT IN PATIENTS WITH ANGINA REQUIRING CARDIAC SURGERY Abstract  similar documents
A. V. Rudakova, M. S. Berezhnova
"... programs to reduce cardiovascular morbidity and mortality is shown. ..."
 
Vol 8, No 4 (2012) UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES Abstract  similar documents
N. F. Puchin'yan, Ya. P. Dovgalevskiy, A. V. Panina
"... cardiovascular diseases is one of the priorities of modern medicine. This therapy usually consists of several ..."
 
Vol 20, No 5 (2024) Lipoprotein(a), atherosclerosis and cardiovascular risk Abstract  similar documents
E. A. Polyakova, Iu. S. Khalimov, E. A. Bazhenova, T. M. Bakher
"... cardiovascular diseases. The atherogenicity of Lp(a) is 6 times higher than that of low-density lipoproteins ..."
 
Vol 18, No 1 (2022) Cardiovascular Effects of Metformin Abstract  similar documents
B. T. Kurmanbekova, A. M. Noruizbaeva
"... , progression and mortality from cardiovascular diseases (CVD). The world communities are faced ..."
 
Vol 9, No 4 (2013) ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT Abstract  similar documents
S. Yu. Martsevich
"... ) and angiotensin receptor blockers (ARB) on cardiovascular diseases outcomes are evaluated. Data of the recent meta ..."
 
Vol 14, No 6 (2018) Cardiovascular Diseases and Drug Treatment in Patients with the History of Cerebral Stroke: Data of the Outpatient Registry REGION Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, O. M. Drapkina, A. N. Vorobyev, A. V. Zagrebelnyy, A. N. Kozminsky, K. A. Moseichuk, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Okshina, E. V. Kudryashov, E. N. Belova, V. G. Klyashtorny, S. A. Boytsov
"... Aim. To evaluate the structure of combined cardiovascular diseases, drug treatment and observation ..."
 
Vol 16, No 2 (2020) The Effect of Pharmacological Preconditioning with Nicorandil before Elective Coronary Stenting on the Long-Term Prognosis of Patients with Stable Coronary Artery Disease Abstract  similar documents
G. N. Soboleva, R. V. Gostishchev, A. N. Rogoza, T. I. Kotkina, A. N. Samko, Yu. A. Karpov
"... ) and cardiovascular events (CVE) in the first year after PCI (secondary endpoint) in patients with stable coronary ..."
 
Vol 10, No 1 (2014) MULTIFACTOR PRIMARY PREVENTION OF ISCHEMIC HEART DISEASE IN MIDDLE-AGED MEN AND ITS EFFICACY (10-YEAR FOLLOW-UP) Abstract  PDF (Eng)  similar documents
A. M. Kalinina
"... Aim. To evaluate in a prospective 10-year follow-up study cardiovascular mortality rate ..."
 
Vol 15, No 2 (2019) Long-Term Outcomes of Pharmacoinvasive Reperfusion Strategy Depending on the Choice of Thrombolytic Agent in ST-Segment Elevation Myocardial Infarction Abstract  similar documents
A. V. Khripun, A. A. Kastanayan, M. V. Malevannyi, Y. V. Kulikovskikh
"... the prevalence of major adverse cardiovascular events and the status of patients who had STEMI ..."
 
Vol 12, No 3 (2016) REPORT ON THE ROUND-TABLE MEETING: "REGISTERS IN CARDIOLOGY: THE BASIC RULES OF MANAGEMENT, MODERN EXPERIENCE AND THE RESULTS OF THEIR CREATION IN THE VARIOUS REGIONS OF THE RUSSIAN FEDERATION" Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, M. M. Loukianov, N. P. Kutishenko
"... of various cardiovascular diseases (CVD) were among participants of the meeting. The importance of modern ..."
 
Vol 18, No 2 (2022) Hostility, Anger, Psycho-emotional Factors and Cardiovascular Disease Abstract  similar documents
G. F. Andreeva, V. M. Gorbunov
"... , hostility, anger and cardiovascular diseases. The first chapter describes the main historical stages ..."
 
Vol 9, No 3 (2013) IMPACT OF LOCUS 9P21.3 SINGLE NUCLEOTIDE POLYMORPHISMS ON CORONARY ATHEROSCLEROSIS SEVERITY AND LONG-TERM OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENT WITH MYOCARDIAL INFARCTION Abstract  similar documents
P. A. Shesternya, G. V. Matyushin, S. Yu. Nikulina, A. S. Sergeeva
"... стенозов, индекс Gensini]. Не обнаружено ассоциации полиморфных вариантов локуса 9р21.3 с отдаленными ..."
 
Vol 15, No 4 (2019) Evidence, Guidelines and Treatment Algorithms for Patients with Arterial Hypertension and Dyslipidemia: the Need for Compromise and Optimization of Tactics in Practical Healthcare Abstract  similar documents
O. M. Drapkina, M. V. Ezhov, S. R. Gilyarevsky, R. N Shepel
"... of cardiovascular complications for primary prevention in a wide population are presented. The question of the ratio ..."
 
Vol 12, No 1 (2016) The main factors affecting the long-term outcomes in patients after acute cerebrovascular disorder: results of the LIS-2 study Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, A. V. Suvorov, A. V. Zagrebelnyy, M. L. Ginzburg, A. D. Deev
"... be largely explained by the poor quality of primary and secondary prevention of cardiovascular events. ..."
 
Vol 14, No 2 (2018) ECONOMIC BURDEN OF CARDIOVASCULAR DISEASES IN THE RUSSIAN FEDERATION IN 2016 Abstract  PDF (Eng)  similar documents
A. N. Kontsevaya, O. M. Drapkina, Yu. A. Balanova, A. E. Imaeva, E. I. Suvorova, M. B. Khudyakov
"... Aim. To evaluate the economic burden of cardiovascular diseases (CVD) in the Russian Federation ..."
 
Vol 7, No 6 (2011) DETERMINANTS OF PREVENTIVE BEHAVIOR REGARDING CARDIOVASCULAR DISEASES AND RISK FACTORS IN PATIENTS WITH ESSENTIAL HYPERTENSION AND CHRONIC ISCHEMIC HEART DISEASE Abstract  similar documents
D. Yu. Platonov, T. A. Kostjuk, A. I. Brandt, O. V. Tsygankova
"... logistic regression. Results. Awareness of the cardiovascular diseases (CVD) and its prevention (odds ratio ..."
 
Vol 17, No 4 (2021) Obstructive sleep apnea and cardiovascular comorbidity: common pathophysiological mechanisms to cardiovascular disease Abstract  similar documents
M. V. Agaltsov, O. M. Drapkina
"... Obstructive sleep apnea (OSA) is associated with many cardiovascular and metabolic diseases. Sleep ..."
 
Vol 5, No 2 (2009) DOCTOR INERTNESS AS A FACTOR DISTURBING EFFECTIVE TREATMENT OF CARDIOVASCULAR DISEASES Abstract  similar documents
E. V. Minakov, R. A. Khokhlov, G. I. Furmenko, N. M. Akhmedzhanov
"... which treat and follow-up patients with cardiovascular diseases (CVD). Material and methods ..."
 
Vol 5, No 1 (2009) CARDIOLOGICAL MANAGEMENT OF PREGNANT WOMEN IN THE UDMURT REPUBLIC Abstract  similar documents
I. R. Gaisin, R. M. Valeeva, L. V. Shilina, N. Yu. Chernisheva, N. I. Maksimov
"... Aim. To assess the efficacy of specialized management of pregnant women with cardiovascular ..."
 
Vol 15, No 5 (2019) Outpatient Register of Patients with Acute Myocardial Infarction: Assessment of the Hypertension Impact on Long-term Prognosis Abstract  similar documents
D. P. Sichinava, E. P. Kalaydzhyan, N. P. Kutishenko, S. Yu. Martsevich
"... . The follow-up duration was 1 year, the incidence of cardiovascular complications (CVC) was estimated: death ..."
 
Vol 12, No 5 (2016) The Value of Subclinical Carotid Atherosclerosis for Primary Prevention of Cardiovascular Diseases. Review of the Main International Studies Abstract  similar documents
E. K. Butina, E. V. Bochkareva
"... Measures for the prevention of cardiovascular diseases (CVD) are more effective ..."
 
Vol 15, No 5 (2019) Efficacy, Safety and Long-term Outcomes of Nicorandil Use in Patients with Stable Ischemic Heart Disease According to the Results of Randomized and Observational Studies Abstract  similar documents
Yu. V. Lukina, N. P. Kutishenko, S. Yu. Martsevich
"... comorbidity was noted (cardiovascular diseases, diabetes mellitus). Drugs that favorably affect the prognosis ..."
 
Vol 16, No 5 (2020) Possible Approaches to Primary Prevention of Cardiovascular Diseases Abstract  similar documents
V. N. Larina, D. S. Mkrtychev, V. A. Kuznetsova, A. A. Tyazhelnikov
"... with the development of cardiovascular diseases (CVD), allowed the experts of the American Heart Association to develop ..."
 
Vol 15, No 2 (2019) Detectability of Subclinical Hypothyroidism and Thyroid Stimulating Hormone Levels Associated with Cardiovascular Diseases in Patients of North-West Region Hospital Abstract  similar documents
A. R. Volkova, O. D. Dygun, O. N. Zhdanova, B. G. Lukichev, L. A. Belyakova, E. M. Sereda
"... with cardiovascular diseases (CVD) is an important clinical task. Aim. To study the detectability of subclinical ..."
 
Vol 16, No 4 (2020) Studying the Possibility of Optimizing the Statin Therapy Algorithm in Outpatient Practice Abstract  similar documents
D. V. Nebieridze, N. M. Akhmedzhanov, S. A. Davitashvili, A. S. Lishuta, A. S. Safaryan
"... to cardiovascular risk require an optimization of their pharmacotherapy in clinical practice. Aim. To study ..."
 
Vol 12, No 4 (2016) Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk Abstract  similar documents
O. M. Drapkina, O. N. Korneeva
"... for a number of cardiovascular diseases (CVD), is considered. The high prevalence of cardiovascular risk ..."
 
Vol 20, No 5 (2024) Impact of non-high-density lipoprotein cholesterol in mortality and cardiovascular events among middle-aged Russian men: 40 years ago and now Abstract  PDF (Eng)  similar documents
S. A. Shalnova, A. E Imaeva, Yu. A Balanova, V. A Kutsenko, A. V Kapustina, V. A Metelskaya, N. A Imaeva, B. M Nazarov, O. E Ivlev, E. B Yarovaya, O. M Drapkina
"... in relation to cardiovascular events, all-cause and cause-specific mortality and among middle-aged Russian men ..."
 
Vol 6, No 3 (2010) BLUMENTHAL SCREENING FOR CARDIOVASCULAR RISK IN ASYMPTOMATIC PATIENTS Abstract  similar documents
J. S. Berger, C. O. Jordan, D. Lloyd-Jones, R.S. Blumenthal
"... Blumenthal screening for cardiovascular risk in asymptomatic patients. ..."
 
Vol 5, No 3 (2009) CLINICAL AND ECONOMICAL RATIONALES OF CARDIOVASCULAR RISK EVALUATION AT WORKPLACE Abstract  similar documents
A. V. Kontsevaya, A. M. Kalinina, Yu. M. Pozdnyakov, S. V. Belonosova, M. B. Khudyakov
"... Aim. To study clinical and economical rationales for cardiovascular risk evaluation at workplace ..."
 
Vol 16, No 5 (2020) The Role of Adherence to Basic Pharmacotherapy of Heart Failure for Prevention of Late Adverse Events in Patients with Coronary Artery Disease and Left Ventricular Dysfunction After Surgical Revascularization of Myocardium Abstract  PDF (Eng)  similar documents
O. A. Yepanchintseva, K. A. Mikhaliev, I. V. Shklianka, O. J. Zharinov, B. M. Todurov
"... ) in prevention of late major adverse events (MAEs) after isolated coronary artery bypass grafting (CABG ..."
 
Vol 15, No 3 (2019) Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 2. Association of Breast Arterial Calcification and Cardiovascular Diseases Abstract  similar documents
E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina
"... the stratification of cardiovascular risk in the female population are of increasing interest. The purpose of the 2 ..."
 
Vol 6, No 4 (2010) ECONOMIC EFFICIENCY OF THE IMPLEMENTATION OF THE PROGRAM OF CARDIOVASCULAR DISEASES MULTIFACTORIAL PREVENTION IN THE ORGANIZED COLLECTIVE OF TECHNICAL RESEARCH INSTITUTE Abstract  similar documents
A. V. Kontsevaya, A. M. Kalinina, S. V. Belonosova, J. M. Pozdnjakov, M. B. Khudyakov
"... Aim. To estimate economic efficiency of a complex of resource-saving activities for cardiovascular ..."
 
Vol 9, No 4 (2013) NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY Abstract  similar documents
A. V. Rudenko, B. A. Rudenko
"... cardiovascular events incidence in patients with atherosclerosis, even if they have no arterial hypertension ..."
 
Vol 16, No 2 (2020) Gut Microbiota Composition and Metabolites as the new Determinants of Cardiovascular Pathology Development Abstract  similar documents
O. M. Drapkina, A. N. Kaburova
"... . In this group cardiovascular diseases (CVD) are known to be the leading cause of death which pathogenesis still ..."
 
Vol 11, No 5 (2015) Excess winter cardiovascular morbidity in Ivanovo Region in 2009-2013 years Abstract  similar documents
A. V. Kontsevaya, J. A. Balanova, M. M. Loukianov, M. B. Khudyakov, O. A. Belova, S. V. Romanchuk
"... a year. Aim. To study excess cardiovascular morbidity during winter in Ivanovo Region in 2009-2013 years ..."
 
Vol 8, No 6 (2012) THE RELATIONSHIP OF CARDIOVASCULAR RISK FACTORS AND ARTERIAL WALL STIFFNESS IN WOMEN WITH A HIGH ACTIVITY OF RHEUMATOID ARTHRITIS Abstract  similar documents
D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov
"... pulse wave) with cardiovascular risk factors in women with rheumatoid arthritis (RA). Material ..."
 
Vol 12, No 1 (2016) CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, N. N. Nikulina, K. G. Pereverzeva, E. A. Pravkina, A. D. Deev, E. V. Kudryashov, E. N. Belova
"... Aim. To study a pattern of concomitant cardiovascular diseases (CVDs) and to estimate ..."
 
Vol 19, No 1 (2023) Microbiota and Cardiovascular Diseases: Mechanisms of Influence and Correction Possibilities Abstract  similar documents
A. V. Gorbenko, Y. P. Skirdenko, K. A. Andreev, M. M. Fedorin, N. A. Nikolaev, M. A. Livzan
"...   types.  The link between the gut microbiota  and cardiovascular disease (CVD) is being actively ..."
 
Vol 11, No 2 (2015) THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT? Abstract  similar documents
S. Yu. Martsevich, O. V. Lerman, N. P. Kutishenko, A. Yu. Suvorov
"... with cardiovascular diseases and concomitant chronic liver diseases. Material and methods. Сross-sectional ..."
 
Vol 11, No 5 (2015) The role of peptide hormones (adiponectin, leptin, insulin) in the pathogenesis of atherosclerosis Abstract  similar documents
S. A. Smetnev, A. N. Meshkov
"... Currently, cardiovascular diseases (CVD) remain the main problem in the world and in Russia ..."
 
Vol 16, No 1 (2020) Patients with Combination of Cardiovascular Diseases and Type 2 Diabetes in RECVASA and REGION Registries: Multimorbidity, Outcomes and Potential Effect of Dapagliflozin in the Russian Clinical Practice Abstract  similar documents
M. M. Loukianov, A. V. Kontsevaya, A. O. Myrzamatova, M. B. Khudyakov, E. Y. Okshina, E. V. Kudryashov
"... of dapagliflozin in patients with a combination of cardiovascular disease (CVD) and type 2 diabetes in Russian ..."
 
Vol 16, No 1 (2020) Arrhythmias in Patients after Surgical Myocardial Revascularization Abstract  similar documents
N. U. Zakirov, A. G. Kevorkov, A. S. Rasulov, E. Y. Tursunov
"... to fatal ventricular heart rhythm disorders and cardiovascular mortality. Along with this, changes ..."
 
Vol 14, No 5 (2018) Drug Therapy Structure and Clinical Characteristics of Patients with Atrial Fibrillation According to Data of REKUR-AF Study Abstract  similar documents
I. L. Polshakova, S. V. Povetkin
"... data, the type and duration of AF, cardiovascular diseases (CVD), concomitant noncardiac pathology ..."
 
Vol 15, No 2 (2019) Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 1. Breast Arterial Calcification: Pathomorphology, Prevalence and Risk Factors Abstract  similar documents
E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina
"... with cardiovascular diseases (CVD). This allows it to be considered as a new marker of cardiovascular risk in women ..."
 
Vol 5, No 1 (2009) CLINICAL SIGNIFICANCE OF HEART RATE VARIABILITY INDEXES DERIVED FROM 5-MINUTE AND 24-HOUR ECG RECORDINGS IN PATIENTS WITH RHEUMATOID ARTHRITIS Abstract  similar documents
D. A. Anichkov, A. A. Platonova
"... association between HRV indexes and cardiovascular risk factors and RA-related clinical characteristics ..."
 
Vol 17, No 5 (2021) Optimum Treatment Strategy in Chronic Coronary Syndromes: the New Trials vs the Current Guidelines Abstract  similar documents
L. L. Bershtein, E. V. Zbyshevskaya, V. E. Gumerova
"... in relation to the prevention of cardiovascular complications, the risk of bleeding and the net clinical ..."
 
Vol 14, No 4 (2018) Role of Gut Microbiota in the Pathogenesis of Cardiovascular Diseases and Metabolic Syndrome Abstract  similar documents
O. M. Drapkina, O. E. Shirobokikh
"... The role of gut microbiota in the pathogenesis of cardiovascular diseases (CVD) and metabolic ..."
 
Vol 15, No 3 (2019) The First Results of the Evaluation of Long-Term Nicorandil Treatment Effect on the Probability of Cardiovascular Complications in Patients with Stable Coronary Artery Disease (Data of Observational NIKEA Study) Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, V. P. Voronina, N. A. Dmitrieva, A. V. Zagrebelnyy, O. V. Lerman, O. V. Gaisenok, T. A. Gomova, A. V. Ezhov, A. D. Kuimov, R. A. Libis, G. V. Matyushin, T. N. Mitroshina, G. I. Nechaeva, I. I. Reznik, V. V. Skibitsky, A. I. Chesnikova, N. V. Dobrynina, S. S. Yakushin
"... Aim. To assess the influence of addition of nicorandil on long-term cardiovascular complications ..."
 
Vol 12, No 6 (2016) CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) Abstract  similar documents
M. Loukianov
"... Aim. To study a pattern of concomitant cardiovascular diseases (CVDs) and to estimate ..."
 
Vol 16, No 2 (2020) Patients with Premature Cardiovascular Diseases in Ambulatory Practice: Demographic Characteristics, Risk Factors and Adherence to the Medical Therapy (Data of RECVASA Registry) Abstract  similar documents
E. Yu. Andreenkо, M. M. Loukianov, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, V. A. Dindikova, A. N. Makoveeva, E. V. Kudryashov, S. A. Boytsov, O. M. Drapkina
"... Aim. To evaluate the gender characteristics, educational level, cardiovascular diseases (CVD) risk ..."
 
Vol 13, No 4 (2017) OCCURRENCE OF THE METABOLIC SYNDROME AND ITS EFFECT ON CARDIOVASCULAR RISK IN PATIENTS WITH GOUT Abstract  similar documents
I. I. Polskaya, I. M. Marusenko, T. I. Kulagina, N. N. Vezikova
"... Aim. To study the prevalence of metabolic syndrome (MS) and total risk of cardiovascular diseases ..."
 
Vol 8, No 5 (2012) HIGH HEART RATE AS A POTENTIAL RISK FACTOR FOR DEVELOPMENT OF CARDIOVASCULAR DISEASES IN WOMEN WITH RHEUMATOID ARTHRITIS Abstract  similar documents
D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov
"... Aim. To study relationship between heart rate (HR) and traditional risk factors for cardiovascular ..."
 
Vol 17, No 4 (2021) Assessment of Arterial Stiffness Using the Cardio-Ankle Vascular Index – What We Know and What We Strive for Abstract  similar documents
A. N. Sumin, A. V. Shcheglova
"... of cardiovascular risk, an indicator of arteriosclerosis, and a predictor of cardiovascular events has been ..."
 
Vol 18, No 2 (2022) Antiarrhythmic and Hemodynamic Effects of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Diseases Abstract  similar documents
A. N. Zakirova, N. E. Zakirova
"... the risk of developing cardiovascular diseases. Experimental studies have shown ω-3 PUFA are exhibiting ..."
 
Vol 13, No 3 (2017) INFLUENCE OF PATIENTS’ PREHOSPITAL ATTENDANCE AT OUTPATIENT CLINICS ON LONG-TERM OUTCOMES OF ACUTE CORONARY SYNDROME: LIS-3 STUDY Abstract  similar documents
Yu. V. Semenova, N. P. Kutishenko, A. V. Zagrebelnyy, M. L. Ginzburg, A. D. Deev, S. Yu. Martsevich
"... (40/320). All-cause mortality and recurrent cardiovascular diseases (nonfatal myocardial infarction ..."
 
Vol 11, No 5 (2015) Perioperative assessment of troponin level in the non-cardiac interventions: is there such a need? Abstract  similar documents
A. N. Sumin
"... состояние связано с неблагоприятным прогнозом как непосредственно после операции, так и в отдаленном периоде ..."
 
Vol 14, No 4 (2018) Hospital Stage of Myocardial Infarction Treatment in 13 Regions of Russian Federation by Results of the International Research Abstract  PDF (Eng)  similar documents
A. V. Kontsevaya, K. Bates, E. A. Goryachkin, N. Bobrova, L. I. Syromiatnikova, Yu. V. Popova, D. Yu. Platonov, I. V. Osipova, A. M. Nedbaikin, T. N. Malorodova, O. A. Mirolyubova, D. V. Kryuchkov, L. A. Khaisheva, A. S. Galyavich, M. V. Franz, A. Yu. Efanov, D. V. Duplyakov, O. M. Drapkina, D. Leon, M. McKee
"... PCI, and 2.2% CABG. Turning to cardiovascular risk factors, 46.2% of patients smoked prior ..."
 
Vol 7, No 3 (2011): РЕКОМЕНДАЦИИ ПО РЕВАСКУЛЯРИЗАЦИИ МИОКАРДА Abstract  similar documents
, , , , , , , , , , , , , , , , , , , , , , , ,
 
Vol 19, No 3 (2023) Nutraceutical support in the prevention and treatment of cardiovascular diseases Abstract  similar documents
E. V. Gracheva, E. A. Starovoytova, E. S. Kulikov, N. A. Kirillova, S. V. Fedosenko, M. A. Balaganskaya, D. V. Kromka
"... Cardiovascular disease is the most common cause of death worldwide. In this regard ..."
 
Vol 7, No 3 (2011) POTASSIUM INTAKE, STROKE, AND CARDIOVASCULAR DISEASE: A META-ANALYSIS OF PROSPECTIVE STUDIES  similar documents
L. D'Elia, G. Barba, F. P. Cappuccio, P. Strazzullo
"... -сосудистых заболеваний (ССЗ). Введение. Cвязь между привычным потреблением калия и частотой сосудистых ..."
 
Vol 20, No 3 (2024) Use of glycoprotein IIb/IIIa inhibitors in myocardial infarction in the Russian Federation, according to the Russian Registry of Acute Myocardial Infarction REGION-IM Abstract  similar documents
N. S. Kostritca, R. M. Rabinovich, R. M. Shakhnovich, I. S. Yavelov, R. G. Gulyan, Yu. K. Rytova, S. N. Tereschenko, A. D. Erlikh, D. V. Pevzner
"... were recorded: cardiovascular events (relapse/repeated AMI, stent thrombosis, revascularisation ..."
 
Vol 17, No 6 (2021) Cardiovascular Diseases and Non-Alcoholic Fatty Liver Disease: Relationship and Pathogenetic Aspects of Pharmacotherapy Abstract  similar documents
A. V. Nelidova, M. A. Livzan, N. A. Nikolaev, T. S. Krolevets
"... The association of non-alcoholic fatty liver disease (NAFLD) and cardiovascular risk is currently ..."
 
Vol 20, No 4 (2024) The evolution of evidence-based methods of acute myocardial infarction treatment: is there any reason for optimism in recent years? Abstract  similar documents
S. Yu. Martsevich
"... отсутствия принципиально новых подходов к лечению острого ИМ, его ближайших и отдаленных исходов. Соблюдение ..."
 
Vol 14, No 1 (2018) SMOKING AS A RISK FACTOR FOR CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 2. Advantages of quitting smoking. Strategies to quit smoking Abstract  similar documents
O. D. Ostroumova, I. I. Kopchjonov, T. F. Guseva
"... reduces the risk of developing stable and unstable angina, acute myocardial infarction, cardiovascular ..."
 
Vol 5, No 3 (2009) CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE Abstract  PDF (Eng)  similar documents
I. E. Sapozhnikova, E. I. Tarlovskaya, E. N. Anufrieva
"... Aim. To evaluate cardiovascular diseases (CVD) treatment in patients with type 2 diabetes mellitus ..."
 
Vol 15, No 6 (2019) Association of Family History of Cardiovascular Diseases in Boys Aged 12-13 Years with Structural and Functional Indicators of the Left Ventricle and Arterial Stiffness in the Age of 43-46 Years (Results of 32-Year Prospective Follow-up) Abstract  similar documents
O. Yu. Isaykina, V. B. Rozanov, A. A. Aleksandrov, I. V. Leontyeva, M. B. Kotova, E. I. Ivanova
"... Aim. To evaluate the association of Family History (FH) of cardiovascular diseases (CVD) in boys ..."
 
Vol 16, No 1 (2020) Obesity and Mechanisms of its Negative Impact on the Cardiovascular System Abstract  similar documents
S. V. Miklishanskaya, L. V. Solomasova, M. A. Mazur
"... , which create prerequisites for the development of cardiovascular diseases, as well as the existing ..."
 
Vol 12, No 3 (2016) CORRELATIONS OF DIFFERENT STRUCTURAL AND FUNCTIONAL CHARACTERISTICS OF ARTERIAL WALL WITH TRADITIONAL CARDIOVASCULAR RISK FACTORS IN HEALTHY PEOPLE OF DIFFERENT AGE. PART 2 Abstract  PDF (Eng)  similar documents
I. D. Strazhesko, O. N. Tkacheva, D. U. Akasheva, E. V. Dudinskaya, M. V. Agaltsov, A. S. Kruglikova, N. V. Brailova, V. S. Pykhtina, E. V. Plokhova, N. V. Sharashkina, O. Yu. Isaykina, V. A. Vygodin, S. A. Boytsov
"... of effective cardiovascular disease (CVD) primary prevention. Such lesions include: arterial wall thickening ..."
 
Vol 10, No 5 (2014) OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov
"... into the outpatient REgistry of CardioVAScular diseAses (RECVASA). 530 of 3690 (14.4%) patients had the diagnosis ..."
 
Vol 19, No 3 (2023) Plasma branched-chain amino acid concentrations in individuals without cardiovascular diseases versus patients diagnosed with hypertension and coronary artery disease Abstract  similar documents
M. V. Kozhevnikova, E. O. Korobkova, A. V. Krivova, A. V. Kukharenko, N. E. Moskaleva, K. M. Shestakova, N. V. Mesonzhnik, A. A. Ageev, A. A. Boldin, A. Brito, S. А. Appolonova, E. V. Privalova, Y. N. Belenkov
"... of cardiovascular risk. The objective of this study was to explore the relationship between plasma BCAAs ..."
 
Vol 17, No 6 (2021) Prehospital Period in Patients with COVID-19: Cardiovascular Comorbidity and Pharmacotherapy During the First Epidemic Wave (Hospital Registry Data) Abstract  similar documents
S. Yu. Martsevich, M. M. Lukyanov, M. M. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, A. V. Zagrebelnyy, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Smirnov, E. V. Kudryashov, I. V. Budaeva, E. S. Nikoshnova, O. E. Karpov, O. M. Drapkina
"... pneumonia (CAP), analyze the duration of the prehospital period, cardiovascular comorbidity and the quality ..."
 
Vol 12, No 2 (2016) CORRELATIONS OF DIFFERENT STRUCTURAL AND FUNCTIONAL CHARACTERISTICS OF ARTERIAL WALL WITH TRADITIONAL CARDIOVASCULAR RISK FACTORS IN HEALTHY PEOPLE OF DIFFERENT AGE. PART 1 Abstract  PDF (Eng)  PDF (Eng)  similar documents
I. D. Strazhesko, O. N. Tkacheva, D. U. Akasheva, E. V. Dudinskaya, M. V. Agaltsov, A. S. Kruglikova, N. V. Brailova, V. S. Pykhtina, E. V. Plokhova, N. V. Sharashkina, O. Yu. Isaykina, V. A. Vygodin, S. A. Boytsov
"... for cardiovascular disease (CVD) grows. The nature of relationship between these indices in people without CVD ..."
 
Vol 16, No 5 (2020) Associations of Blood Pressure and Heart Rate and Their Contribution to the Development of Cardiovascular Complications and All-Cause Mortality in the Russian Population of 25-64 Years Abstract  similar documents
S. A. Shalnova, V. A. Kutsenko, A. V. Kapustina, E. B. Yarovaya, Yu. A. Balanova, S. E. Evstifeeva, A. E. Imaeva, S. A. Maksimov, G. A. Muromtseva, N. V. Kulakova, O. N. Kalachikova, T. M. Chernykh, O. A. Belova, G. V. Artamonova, E. V. Indukaeva, Yu. I. Grinshtein, R. A. Libis, D. V. Duplyakov, O. P. Rotar, I. A. Trubacheva, V. N. Serebryakova, A. Yu. Efanov, A. O. Konradi, S. A. Boytsov, O. M. Drapkina
"... cardiovascular diseases (CVD) and mortality from all causes. Material and methods. Prospective observation ..."
 
Vol 14, No 5 (2018) Economic losses due to low coverage of lipid-lowering therapy in patients with cardiovascular diseases in the Russian Federation Abstract  similar documents
Yu. A. Balanova, A. V. Kontsevaya, A. E. Imaeva, O. I. Karpov, M. B. Khudyakov
"... ) in patients with cardiovascular diseases (CVD) and hypercholesterolemia (HCS) in the Russian population ..."
 
Vol 20, No 6 (2024) An in-depth study of the association of breast arterial calcification with cardiovascular disease, its risk factors, and other chronic noncommunicable diseases: rationale and study protocol Abstract  similar documents
I. V. Kim, E. V. Bochkareva, E. K. Butina, O. V. Molchanova, N. Kh. Bayramkulova, E. M. Filichkina, E. B. Yarovaya, O. M. Drapkina
"... and biochemical markers of cardiovascular risk, asymptomatic and clinically expressed forms of cardiovascular ..."
 
Vol 14, No 4 (2018) Association of Conventional Cardiovascular Risk Factors with Carotid Atherosclerosis Prevalence in General Population Abstract  similar documents
V. S. Kaveshnikov, V. N. Serebryakova, I. A. Trubacheva, S. A. Shalnova
"... (ССЗ) и частотой выявления каротидного атеросклероза (КАС) в неорганизованной популяции. Материал и ..."
 
Vol 5, No 3 (2009) ARTERIAL STIFFNESS PARAMETERS IN PATIENTS WITH MODERATE/HIGH CARDIOVASCULAR RISK DURING LISINOPRIL AND SIMVASTATIN TREATMENT Abstract  similar documents
V. N. Isakova, O. G. Garbuzova, E. V. Klinkova, E. V. Bandurko
"... with moderate/high cardiovascular risk receiving lisinopril and simvastatin. Material and methods. 20 patients ..."
 
Vol 16, No 4 (2020) From Low-Dose Fixed Combinations for Arterial Hypertension Treatment to Multi-Target Therapy of Cardiovascular Diseases Abstract  similar documents
P. A. Lebedev, A. A. Garanin
"... as the most effective approach to the fight against cardiovascular diseases (CVD). The priority of domestic ..."
 
Vol 13, No 4 (2017) PATIENTS WITH ATRIAL FIBRILLATION IN MULTIDISCIPLINARY HOSPITAL: STRUCTURE OF HOSPITALIZATION, CONCOMITANT CARDIOVASCULAR DISEASES AND DRUG TREATMENT (DATA OF RECVASA AF-TULA REGISTRY) Abstract  similar documents
M. N. Valiakhmetov, T. A. Gomova, M. M. Loukianov, S. Yu. Martsevich, K. N. Nadejkina, M. N. Artemova, D. N. Jilin, E. E. Fedotova, A. V. Zagrebelnyy, E. V. Kudryashov, S. A. Boytsov
"... cardiovascular diseases (CVD) and drug therapy within the RECVAZA AF-Tula hospital registry. Material ..."
 
Vol 17, No 1 (2021) Optimization of the Statin Therapy Algorithm in Outpatient Practice: Adherence and Economic Benefits Abstract  similar documents
S. A. Davitashvili, D. V. Nebieridze, N. M. Akhmedzhanov, A. S. Lishuta, A. S. Safaryan
"... or secondary prevention of cardiovascular diseases is included in a non-randomized trial. Patients are divided ..."
 
Vol 18, No 4 (2022) Detection and Treatment of Hyperuricemia in Clinical Practice (According to the PROFILE Outpatient Registry) Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, A. V. Zagrebelnyy, Yu. V. Lukina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, S. V. Blagodatskikh, I. V. Budaeva, E. S. Nekoshnova, O. M. Drapkina
"... cardiovascular risk and the frequency of prescribing drugs that lower serum uric acid (sUA) levels in real ..."
 
Vol 19, No 2 (2023) Prognosis of Adverse Outcomes in the Research of Coronary Blood Flow During Echocardiography Abstract  similar documents
E. S. Kalinina, A. V. Zagatina, S. A. Sayganov
"... infarction (MI), death/ MI, myocardial revascularization operations - stenting and aortocoronary bypass (CABG ..."
 
Vol 1, No 1 (2005) TOBACCO DEPENDENCE TREATMENT WITH NICOTINE REPLACEMENT THERAPY AS ONE OF THE METHODS FOR CARDIOVASCULAR DISEASE RISK REDUCTION Abstract  similar documents
O. V. Vikhireva, S. A. Shalnova, A. D. Deev
"... to quit smoking. To assess expected reduction of cardiovascular disease (CVD) and total mortality relative ..."
 
Vol 20, No 2 (2024) The relationship of arterial hypertension, elevated low-density lipoprotein cholesterol and their combination with the occurrence of new cases of cardiovascular diseases in men and women of working age Abstract  similar documents
S. A. Shalnova, E. B. Yarovaya, V. A. Metelskaya, E. M. Filichkina, A. V. Kapustina, V. A. Kutsenko, Yu. A. Balanova, A. E. Imaeva, G. A. Muromtseva, S. E. Evstifeeva, S. A. Maksimov, N. V. Kulakova, O. N. Kalachikova, T. M. Chernykh, O. A. Belova, G. V. Artamonova, Yu. I. Grinshtein, R. A. Libis, O. P Rotar, I. A. Trubacheva, A. Yu. Efanov, S. S. Yakushin, A. N. Redko, I. A. Viktorova, N. N. Prishchepa, A. O. Konradi, S. A. Boytsov, E. V Shlyakhto, O. M. Drapkina
"... (Epidemiology of cardiovascular diseases in various regions of the Russian Federation)". A multi-s tage cluster ..."
 
Vol 15, No 1 (2019) Factors Associated with Cause-Specific Death in Russia. Data from Longitudinal Prospective Study 1977-2001 Abstract  PDF (Eng)  similar documents
S. A. Shalnova, A. V. Kapustina, A. D. Deev, Yu. A. Balanova
"... and their associations with cause-specific mortalities: coronary heart disease (CHD), stroke, cardiovascular diseases ..."
 
Vol 16, No 1 (2020) Alirocumab Administration Experience to Achieve Low Density Lipoprotein Cholesterol Target Levels in Secondary Prevention of Cardiovascular Disease Abstract  similar documents
A. E. Nikitin, E. E. Averin, D. E. Rozhkov, A. V. Sozykin, G. A. Procenko
"... , alirocumab, on lipid levels in patients who receive secondary prevention of cardiovascular diseases (CVD ..."
 
1 - 100 of 748 Items 1 2 3 4 5 6 7 8 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)